KPIT Technologies shares plunged after the company issued a weak preliminary Q1 FY27 business update, prompting several brokerages, includi...

KPIT Technologies witnessed a significant 17% stock plunge following a revenue slowdown warning for Q1FY27, primarily due to unexpected cut...

KPIT Technologies shares plunged 17% after the company warned of a revenue drop in Q1 FY27, citing unexpected actions from European automak...

Cupid shares gained 2% as the company anticipates a record Q1 FY27 revenue exceeding Rs 150 crore. Buoyed by strong market visibility, Cupi...

Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The ...

Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...

HAL has declared a final dividend of Rs 10 per share (200%) for FY26, subject to shareholder approval at the upcoming AGM. The record date ...

Nomura expects consumer staples to deliver a strong start to FY27, forecasting double-digit sales growth for several companies in the June ...

Indian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...

A significant data breach settlement from Alera Group Inc. offers thousands of Americans a chance for compensation, with a filing deadline ...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

Brokerages remain divided on two stocks. Goldman Sachs retained its 'Sell' rating on Bharat Dynamics, raising the target price marginally t...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Health officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...

Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...

Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...

India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...